Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design, synthesis and anticancer properties of isocombretapyridines as potent colchicine binding site inhibitors
Shuai Wen, Xinnan Li, Wenlong Li, et al.
European Journal of Medicinal Chemistry (2020) Vol. 197, pp. 112308-112308
Open Access | Times Cited: 18

Showing 18 citing articles:

Synthesis and Screening of Novel 2,4-Bis Substituted quinazolines as Tubulin Polymerization Promotors and Antiproliferative Agents
Ashish Ranjan Dwivedi, Vijay Kumar, Vikash Prashar, et al.
RSC Medicinal Chemistry (2025)
Closed Access
Indazole-based microtubule-targeting agents as potential candidates for anticancer drugs discovery
Dilipkumar Pal, In‐ho Song, Shrikant Dashrath Warkad, et al.
Bioorganic Chemistry (2022) Vol. 122, pp. 105735-105735
Closed Access | Times Cited: 26
An Update on the Recent Advances and Discovery of Novel Tubulin Colchicine Binding Inhibitors
Haoxiang Weng, Jinlong Li, Huajian Zhu, et al.
Future Medicinal Chemistry (2023) Vol. 15, Iss. 1, pp. 73-95
Open Access | Times Cited: 12
Discovery of a Novel Vascular Disrupting Agent Inhibiting Tubulin Polymerization and HDACs with Potent Antitumor Effects
Huajian Zhu, Yuchen Tan, Chen He, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 16, pp. 11187-11213
Closed Access | Times Cited: 19
Novel topical and transdermal delivery of colchicine with chitosan based biocomposite nanofiberous system; formulation, optimization, characterization, ex vivo skin deposition/permeation, and anti-melanoma evaluation
Hamed Morad, Mohsen Jahanshahi, Jafar Âkbari, et al.
Materials Chemistry and Physics (2021) Vol. 263, pp. 124381-124381
Closed Access | Times Cited: 26
SAR Investigation and Discovery of Water-Soluble 1-Methyl-1,4-dihydroindeno[1,2-c]pyrazoles as Potent Tubulin Polymerization Inhibitors
Yingjie Cui, Chao Liu, Chenchen Ma, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 23, pp. 14840-14866
Closed Access | Times Cited: 23
Discovery of novel N-benzylbenzamide derivatives as tubulin polymerization inhibitors with potent antitumor activities
Huajian Zhu, Wenlong Li, Shuai Wen, et al.
European Journal of Medicinal Chemistry (2021) Vol. 216, pp. 113316-113316
Open Access | Times Cited: 22
Design, synthesis and bioevaluation of 6-aryl-1-(3,4,5-trimethoxyphenyl)-1H-benzo[d]imidazoles as tubulin polymerization inhibitors
Runlai Liu, Mingxin Huang, Shuai Zhang, et al.
European Journal of Medicinal Chemistry (2021) Vol. 226, pp. 113826-113826
Closed Access | Times Cited: 19
Discovery and biological evaluation of 4,6-pyrimidine analogues with potential anticancer agents as novel colchicine binding site inhibitors
Jifa Zhang, Lun Tan, Chengyong Wu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 248, pp. 115085-115085
Closed Access | Times Cited: 7
Discovery of a Dual Tubulin and Neuropilin-1 (NRP1) Inhibitor with Potent In Vivo Anti-Tumor Activity via Pharmacophore-based Docking Screening, Structure Optimization, and Biological Evaluation
Lufeng Zheng, Yunting Zou, Tianyuan Xie, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 23, pp. 16187-16200
Closed Access | Times Cited: 6
A novel tubulin inhibitor, 6h, suppresses tumor-associated angiogenesis and shows potent antitumor activity against non–small cell lung cancers
Zi Liu, Liancheng Huang, Tianhao Zhou, et al.
Journal of Biological Chemistry (2022) Vol. 298, Iss. 7, pp. 102063-102063
Open Access | Times Cited: 10
Synthesis and screening of novel 4-N-heterocyclic-2-aryl-6,7,8-trimethoxyquinazolines as antiproliferative and tubulin polymerization inhibitors
Ashish Ranjan Dwivedi, Suraj Singh Rawat, Vijay Kumar, et al.
Bioorganic & Medicinal Chemistry (2022) Vol. 72, pp. 116976-116976
Closed Access | Times Cited: 10
Palladium-Mediated Bioorthogonal System for Prodrug Activation of N-Benzylbenzamide-Containing Tubulin Polymerization Inhibitors for the Treatment of Solid Tumors
Jinlong Li, Tong Zhang, Di Wu, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 21, pp. 19905-19924
Closed Access | Times Cited: 1
Design, synthesis and antitumor evaluation of novel chiral diaryl substituted azetidin-2-one derivatives as tubulin polymerization inhibitors
Yuru Liang, Mao Zhang, Pengfei Zhou, et al.
Bioorganic Chemistry (2021) Vol. 115, pp. 105239-105239
Closed Access | Times Cited: 10
Design, Synthesis, and Antipoliferative Activities of Novel Substituted Imidazole-Thione Linked Benzotriazole Derivatives
Ahdab N. Khayyat, Khaled O. Mohamed, Azizah M. Malebari, et al.
Molecules (2021) Vol. 26, Iss. 19, pp. 5983-5983
Open Access | Times Cited: 10
The Potential Strategies for Overcoming Multidrug Resistance and Reducing Side Effects of Monomer Tubulin Inhibitors for Cancer Therapy
Yingjie Cui, Jing Zhang, Guifang Zhang
Current Medicinal Chemistry (2023) Vol. 31, Iss. 14, pp. 1874-1895
Closed Access | Times Cited: 2
Methylsulfanylpyridine based diheteroaryl isocombretastatin analogs as potent anti-proliferative agents
Raquel Álvarez, Laura Aramburu, Consuelo Gajate, et al.
European Journal of Medicinal Chemistry (2020) Vol. 209, pp. 112933-112933
Open Access | Times Cited: 6
Kojic Acid Derivative as an Antimitotic Agent That Selectively Kills Tumour Cells
Giuseppina Pichiri, Marco Piludu, Terenzio Congiu, et al.
Pharmaceuticals (2024) Vol. 18, Iss. 1, pp. 11-11
Open Access
Page 1

Scroll to top